Wen-Quan Wang

1.2k total citations
20 papers, 903 citations indexed

About

Wen-Quan Wang is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Wen-Quan Wang has authored 20 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Wen-Quan Wang's work include Pancreatic and Hepatic Oncology Research (17 papers), Neuroendocrine Tumor Research Advances (8 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Wen-Quan Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Neuroendocrine Tumor Research Advances (8 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Wen-Quan Wang collaborates with scholars based in China, Canada and United States. Wen-Quan Wang's co-authors include Xianjun Yu, Hua-Xiang Xu, Liang Liu, Chun-Tao Wu, Quan-Xing Ni, He-Li Gao, Jin-Zhi Xu, Shi-Rong Zhang, Zi-Hao Qi and Jin Xu and has published in prestigious journals such as PLoS ONE, Medicine and World Journal of Gastroenterology.

In The Last Decade

Wen-Quan Wang

20 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen-Quan Wang China 16 583 316 273 167 149 20 903
Hua-Xiang Xu China 15 574 1.0× 311 1.0× 268 1.0× 166 1.0× 146 1.0× 19 886
Chun-Tao Wu China 14 545 0.9× 324 1.0× 263 1.0× 164 1.0× 143 1.0× 19 877
Guido Giordano Italy 16 493 0.8× 267 0.8× 225 0.8× 179 1.1× 104 0.7× 76 916
Wenhui Lou China 19 582 1.0× 418 1.3× 388 1.4× 180 1.1× 233 1.6× 62 1.1k
Nigel C. Bird United Kingdom 17 467 0.8× 373 1.2× 257 0.9× 150 0.9× 260 1.7× 28 1.1k
Dan‐Yun Ruan China 17 407 0.7× 286 0.9× 285 1.0× 143 0.9× 117 0.8× 50 935
Guoshuang Shen China 14 538 0.9× 298 0.9× 219 0.8× 356 2.1× 144 1.0× 61 1000
Xiaodong Tian China 17 480 0.8× 531 1.7× 397 1.5× 176 1.1× 226 1.5× 73 1.2k
Seongyeol Park South Korea 17 430 0.7× 322 1.0× 190 0.7× 209 1.3× 129 0.9× 33 971
Miao-Fen Chen Taiwan 17 439 0.8× 300 0.9× 166 0.6× 167 1.0× 225 1.5× 18 974

Countries citing papers authored by Wen-Quan Wang

Since Specialization
Citations

This map shows the geographic impact of Wen-Quan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Quan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Quan Wang more than expected).

Fields of papers citing papers by Wen-Quan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Quan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Quan Wang. The network helps show where Wen-Quan Wang may publish in the future.

Co-authorship network of co-authors of Wen-Quan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Quan Wang. A scholar is included among the top collaborators of Wen-Quan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Quan Wang. Wen-Quan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuo, Hua-Xiang Xu, Hao Li, et al.. (2020). Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World Journal of Gastroenterology. 26(8). 828–838. 117 indexed citations
2.
Li, Hao, Shi-Rong Zhang, Hua-Xiang Xu, et al.. (2019). SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer. Journal of Cancer. 10(12). 2670–2678. 24 indexed citations
3.
Xu, Jin-Zhi, Wen-Quan Wang, Hua-Xiang Xu, et al.. (2019). The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer. Journal of Cancer. 10(17). 4123–4131. 15 indexed citations
4.
Xu, Hua-Xiang, et al.. (2019). Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor. World Journal of Gastroenterology. 25(41). 6248–6257. 28 indexed citations
5.
Wang, Wen-Quan, Liang Liu, Jin-Zhi Xu, & Xianjun Yu. (2019). Reflections on depletion of tumor stroma in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(2). 267–272. 17 indexed citations
6.
Gao, He-Li, Liang Liu, Zi-Hao Qi, et al.. (2018). The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis. Hepatobiliary & pancreatic diseases international. 17(2). 95–100. 50 indexed citations
7.
Qi, Zi-Hao, Hua-Xiang Xu, Shi-Rong Zhang, et al.. (2018). The Significance of Liquid Biopsy in Pancreatic Cancer. Journal of Cancer. 9(18). 3417–3426. 39 indexed citations
8.
Xu, Hua-Xiang, Shuo Li, Chun-Tao Wu, et al.. (2018). Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma. Pancreatology. 18(6). 671–677. 19 indexed citations
9.
Li, Shuo, Hua-Xiang Xu, Chun-Tao Wu, et al.. (2018). Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 22(1). 15–36. 218 indexed citations
10.
Zhang, Shi-Rong, Hao Li, Wen-Quan Wang, et al.. (2018). Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma. European Journal of Surgical Oncology. 45(5). 769–775. 11 indexed citations
11.
Xu, Jin-Zhi, Wen-Quan Wang, Shi-Rong Zhang, et al.. (2018). Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer. Current Medicinal Chemistry. 26(40). 7196–7211. 10 indexed citations
12.
Qi, Zi-Hao, Hua-Xiang Xu, Shi-Rong Zhang, et al.. (2018). RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling. International Journal of Oncology. 52(4). 1105–1116. 41 indexed citations
13.
Xu, Jin-Zhi, Wen-Quan Wang, Shi-Rong Zhang, et al.. (2017). Intrinsic Contact Between T and N Classifications in Resected Well–Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms. Annals of Surgical Oncology. 25(3). 647–654. 6 indexed citations
14.
Xu, Hua-Xiang, Liang Liu, Wen-Quan Wang, et al.. (2016). Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Surgery. 161(2). 373–384. 43 indexed citations
15.
Liu, Liang, Hua-Xiang Xu, Wen-Quan Wang, et al.. (2016). Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget. 7(5). 5943–5956. 83 indexed citations
16.
17.
Xu, Hua-Xiang, Tao Chen, Wen-Quan Wang, et al.. (2014). Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. European Journal of Nuclear Medicine and Molecular Imaging. 41(6). 1093–1102. 70 indexed citations
18.
Wang, Wen-Quan, Liang Liu, Hua-Xiang Xu, et al.. (2014). The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib. Oncotarget. 5(11). 3895–3906. 17 indexed citations
19.
Liu, Liang, et al.. (2013). Significance of Caveolin-1 Regulators in Pancreatic Cancer. Asian Pacific Journal of Cancer Prevention. 14(8). 4501–4507. 8 indexed citations
20.
Wang, Wen-Quan, Liang Liu, Hua-Xiang Xu, et al.. (2013). Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer. PLoS ONE. 8(8). e71189–e71189. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua-Xiang Xu Breakdown of academic impact, for papers by Chun-Tao Wu Breakdown of academic impact, for papers by Guido Giordano Breakdown of academic impact, for papers by Wenhui Lou Breakdown of academic impact, for papers by Nigel C. Bird Breakdown of academic impact, for papers by Dan‐Yun Ruan Breakdown of academic impact, for papers by Guoshuang Shen Breakdown of academic impact, for papers by Xiaodong Tian Breakdown of academic impact, for papers by Seongyeol Park Breakdown of academic impact, for papers by Miao-Fen Chen
Rankless by CCL
2026